Cost-Sharing Incentives Would Drive Higher Generic Drug Use By Low-Income Enrollees In Part D - MedPAC
This article was originally published in The Pink Sheet Daily
Executive Summary
Staff analysis found beneficiaries receiving subsidies have high brand use in categories where generics are available, including antipsychotics, diabetes, peptic ulcer treatment, cholesterol therapy.